Anagram Therapeutics Funding: $250M Raised, Growth (2024)

Anagram Therapeutics is based in Natick. It has raised $250M in total funding. Latest round: Growth. Backed by Blackstone Life Sciences.

Anagram Therapeutics funding overview

Anagram Therapeutics is based in Natick. Anagram Therapeutics has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in October 2024. The round record for Anagram Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Blackstone Life Sciences.

Anagram Therapeutics at a glance

Total raised
$250M
Latest round
Growth
Latest round date
October 2024
Headquarters
Natick
Notable investors
Blackstone Life Sciences

Frequently asked about Anagram Therapeutics funding

How much has Anagram Therapeutics raised?
Anagram Therapeutics has raised $250M in total disclosed funding across the rounds on record.
Who has invested in Anagram Therapeutics?
Blackstone Life Sciences are named among the investors backing Anagram Therapeutics.
What was the latest Anagram Therapeutics funding round?
The most recent disclosed round is a Growth, announced in October 2024.
Where is Anagram Therapeutics based?
Anagram Therapeutics is based in Natick.
When did Anagram Therapeutics last raise?
The last disclosed Anagram Therapeutics round closed in October 2024 at Growth.

Round data for Anagram Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Natick and backer lists below.

Companies related to Anagram Therapeutics (13)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026